Companies that own Formycon AG
MPPM Manfred Piontke Portfolio Management e.K.
170,000
1.87%
0
6.35%
03/31/2018
Matejka & Partner Asset Management GmbH
118,210
1.3%
28,882
2.96%
12/31/2017
Bellevue Asset Management AG
65,454
0.72%
246
0.04%
05/31/2018
PMG Fonds Management AG
56,000
0.62%
0
0.68%
05/31/2018
Wyss & Partner Vermögensverwaltung und Anlageberatung AG
38,666
0.43%
0
2.11%
01/31/2018
Bayerische Vermögen Asset Management AG
24,480
0.27%
2,700
0.7%
07/31/2018
Deka Investment GmbH
17,949
0.2%
6,851
0%
05/30/2018
PEH Wertpapier AG (Germany)
17,000
0.19%
0
0.4%
07/31/2018
KIRIX Vermögensverwaltung AG
15,000
0.17%
0
0.38%
09/30/2017
Plutos Vermögensverwaltung AG
15,000
0.17%
15,000
0.99%
09/30/2017
| Address |
Fraunhoferstraße 15
Munich Bayern (Bavaria) 82152
Germany
|
|
Employees
|
- |
| Website |
http://formycon.com |
| Updated |
07/08/2019 |
| Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205 which focusoin the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany. |
